This month’s editorial by Contributing Editor, Ashley Krull, Ph.D., introduces (or re-introduces) members to the concept of mesenchymal stromal cells (MSCs) that have been engineered to express a chimeric antigen receptor (CAR). These CAR-MSCs may seem new to many but have actually been studied for a while, with the latest iteration designed to combine the beneficial effects of antigen targeting and immunosuppression at sites of immune cell-induced damage. The editorial serves as a primer for CAR-MSCs with hopefully more education to follow in Telegraft! Read More